[
    [
        {
            "time": "",
            "original_text": "国金证券维持华兰生物买入评级：经营现金流良好，静待各大业务放量",
            "features": {
                "keywords": [
                    "华兰生物",
                    "买入评级",
                    "经营现金流",
                    "业务放量"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国金证券维持华兰生物买入评级：经营现金流良好，静待各大业务放量",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "明星私募一季度调仓：冯柳现身25家公司持仓超300亿 高瓴礼仁新进安图生物、伊利",
            "features": {
                "keywords": [
                    "明星私募",
                    "冯柳",
                    "高瓴礼仁",
                    "安图生物",
                    "伊利"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "食品饮料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "明星私募一季度调仓：冯柳现身25家公司持仓超300亿 高瓴礼仁新进安图生物、伊利",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "北上资金加仓多只绩优疫苗股，9股增持超亿",
            "features": {
                "keywords": [
                    "北上资金",
                    "加仓",
                    "绩优疫苗股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金加仓多只绩优疫苗股，9股增持超亿",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "千亿白酒股直线跌停！郭广昌又笑了，发生了什么",
            "features": {
                "keywords": [
                    "白酒股",
                    "跌停",
                    "郭广昌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "食品饮料"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "千亿白酒股直线跌停！郭广昌又笑了，发生了什么",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "平安证券给予华兰生物推荐评级，高基数下血制品销售稍有下滑，疫苗持续扩产中",
            "features": {
                "keywords": [
                    "华兰生物",
                    "推荐评级",
                    "血制品",
                    "疫苗",
                    "扩产"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券给予华兰生物推荐评级，高基数下血制品销售稍有下滑，疫苗持续扩产中",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "平安证券：华兰生物（002007.SZ）后疫情时代血制品需求回归常态，维持“推荐”评级",
            "features": {
                "keywords": [
                    "华兰生物",
                    "后疫情时代",
                    "血制品",
                    "需求回归常态",
                    "推荐评级"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券：华兰生物（002007.SZ）后疫情时代血制品需求回归常态，维持“推荐”评级",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "每日“药”闻|兆科眼科上市首日破发，收跌14.76%；君实生物一季度盈利3.61亿元",
            "features": {
                "keywords": [
                    "兆科眼科",
                    "破发",
                    "君实生物",
                    "盈利"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "每日“药”闻|兆科眼科上市首日破发，收跌14.76%；君实生物一季度盈利3.61亿元",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "年报收官 河南A股上市公司去年共营收6607亿元 其中1家过千亿",
            "features": {
                "keywords": [
                    "年报",
                    "河南A股",
                    "营收",
                    "过千亿"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "年报收官 河南A股上市公司去年共营收6607亿元 其中1家过千亿",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]